For the quarter ending 2026-03-31, PRCT has $487,062K in assets. $139,395K in debts. $245,641K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 245,641 | 286,503 | 294,281 | 302,717 |
| Accounts receivable, net | 96,388 | 83,533 | 84,504 | 80,817 |
| Inventory | 77,536 | 70,694 | 66,715 | 67,032 |
| Prepaid expenses and other current assets | 8,469 | 9,648 | 9,252 | 7,501 |
| Total current assets | 428,034 | 450,378 | 454,752 | 458,067 |
| Restricted cash, non-current | 3,038 | 3,038 | 3,038 | 3,038 |
| Property and equipment, net | 31,739 | 30,399 | 30,022 | 28,602 |
| Operating lease right-of-use assets, net | 17,162 | 17,538 | 17,904 | 18,260 |
| Intangible assets, net | 640 | 709 | 727 | 795 |
| Other assets | 6,449 | 6,019 | 5,098 | 4,292 |
| Total assets | 487,062 | 508,081 | 511,541 | 513,054 |
| Loan facility derivative liability | - | 0 | 0 | 0 |
| Accounts payable | 18,851 | 17,285 | 11,118 | 11,783 |
| Accrued compensation | 18,476 | 23,175 | 21,797 | 16,302 |
| Deferred revenue | 13,702 | 13,048 | 10,665 | 9,889 |
| Operating lease, current | 2,358 | 2,214 | 2,135 | 2,059 |
| Other current liabilities | 10,249 | 10,073 | 8,183 | 9,694 |
| Total current liabilities | 63,636 | 65,795 | 53,898 | 49,727 |
| Long-term debt | 51,664 | 51,615 | 51,566 | 51,524 |
| Operating lease, non-current | 23,974 | 24,654 | 25,225 | 25,784 |
| Other non-current liabilities | 121 | 147 | 576 | 223 |
| Total liabilities | 139,395 | 142,211 | 131,265 | 127,258 |
| Additional paid-in capital | 1,020,881 | 1,007,390 | 991,945 | 976,240 |
| Accumulated other comprehensive gain (loss) | -19 | 37 | 42 | -144 |
| Accumulated deficit | -673,195 | -641,557 | -611,711 | -590,300 |
| Total stockholders equity | 347,667 | 365,870 | 380,276 | 385,796 |
| Total liabilities and stockholders equity | 487,062 | 508,081 | 511,541 | 513,054 |
PROCEPT BioRobotics Corp (PRCT)
PROCEPT BioRobotics Corp (PRCT)